Sheila Santhappa, MD - Medicare Neurology in New Britain, CT

Sheila Santhappa, MD is a medicare enrolled "Psychiatry & Neurology - Neurology" physician in New Britain, Connecticut. She graduated from medical school in 2002 and has 22 years of diverse experience with area of expertise as Neurology. She is a member of the group practice The Charlotte Hungerford Hospital and her current practice location is 100 Grand St, New Britain, Connecticut. You can reach out to her office (for appointments etc.) via phone at (608) 224-5305.

Sheila Santhappa is licensed to practice in Connecticut (license number 63748) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1013116730.

Contact Information

Sheila Santhappa, MD
100 Grand St,
New Britain, CT 06052-2016
(608) 224-5305
Not Available



Physician's Profile

Full NameSheila Santhappa
GenderFemale
SpecialityNeurology
Experience22 Years
Location100 Grand St, New Britain, Connecticut
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Sheila Santhappa graduated from medical school in 2002
  NPI Data:
  • NPI Number: 1013116730
  • Provider Enumeration Date: 07/12/2007
  • Last Update Date: 05/17/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0345485389
  • Enrollment ID: I20190805002310

Medical Identifiers

Medical identifiers for Sheila Santhappa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013116730NPI-NPPES
14RC5OtherFLBCBS
4947399OtherFLAETNA
009649700MedicaidFL
3522839OtherFLCIGNA
P01224659OtherFLRAILROAD MEDICARE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084N0400XPsychiatry & Neurology - Neurology MD60342170 (Washington)Secondary
2084N0400XPsychiatry & Neurology - Neurology ME117068 (Florida)Secondary
2084N0400XPsychiatry & Neurology - Neurology 63748 (Connecticut)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Charlotte Hungerford HospitalTorrington, CTHospital
Hartford HospitalHartford, CTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
The Charlotte Hungerford Hospital4486557501159

News Archive

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.

Fetal exposure to crude oil chemical may increase risk of heart disease

While it may be years before the health effects of the 2010 oil spill in the Gulf of Mexico are known, a new study shows that fetal exposure to a chemical found in crude oil is associated with an increased risk of congenital heart disease.

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

Novel immunotherapeutic shows promise against chronic hepatitis B

A novel immunotherapeutic in early development for chronic hepatitis B (CHB), TG1050, has been shown to reach the clinical goals that are considered to be the hallmarks of a cure for CHB, according to results revealed today at The International Liver Congress 2015.

Sachs says he is 'eager for challenge' of World Bank presidency

The new president of the World Bank "should come to office understanding the realities of flooded villages, drought-ridden farms, desperate mothers hovering over comatose, malaria-infected children, and teenage girls unable to pay high school tuition. More than knowing these realities, and caring to end them, the bank president should understand their causes and interconnected solutions," Jeffrey Sachs, director of the Earth Institute at Columbia University, writes in a Washington Post opinion piece.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sheila Santhappa allows following entities to bill medicare on her behalf.
Entity NameThe Hospital Of Central Connecticut At New Britain General And Bradley
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063461481
PECOS PAC ID: 6507776564
Enrollment ID: O20040115000497

News Archive

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.

Fetal exposure to crude oil chemical may increase risk of heart disease

While it may be years before the health effects of the 2010 oil spill in the Gulf of Mexico are known, a new study shows that fetal exposure to a chemical found in crude oil is associated with an increased risk of congenital heart disease.

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

Novel immunotherapeutic shows promise against chronic hepatitis B

A novel immunotherapeutic in early development for chronic hepatitis B (CHB), TG1050, has been shown to reach the clinical goals that are considered to be the hallmarks of a cure for CHB, according to results revealed today at The International Liver Congress 2015.

Sachs says he is 'eager for challenge' of World Bank presidency

The new president of the World Bank "should come to office understanding the realities of flooded villages, drought-ridden farms, desperate mothers hovering over comatose, malaria-infected children, and teenage girls unable to pay high school tuition. More than knowing these realities, and caring to end them, the bank president should understand their causes and interconnected solutions," Jeffrey Sachs, director of the Earth Institute at Columbia University, writes in a Washington Post opinion piece.

Read more Medical News

› Verified 6 days ago

Entity NameThe Charlotte Hungerford Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629075734
PECOS PAC ID: 4486557501
Enrollment ID: O20040128000183

News Archive

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.

Fetal exposure to crude oil chemical may increase risk of heart disease

While it may be years before the health effects of the 2010 oil spill in the Gulf of Mexico are known, a new study shows that fetal exposure to a chemical found in crude oil is associated with an increased risk of congenital heart disease.

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

Novel immunotherapeutic shows promise against chronic hepatitis B

A novel immunotherapeutic in early development for chronic hepatitis B (CHB), TG1050, has been shown to reach the clinical goals that are considered to be the hallmarks of a cure for CHB, according to results revealed today at The International Liver Congress 2015.

Sachs says he is 'eager for challenge' of World Bank presidency

The new president of the World Bank "should come to office understanding the realities of flooded villages, drought-ridden farms, desperate mothers hovering over comatose, malaria-infected children, and teenage girls unable to pay high school tuition. More than knowing these realities, and caring to end them, the bank president should understand their causes and interconnected solutions," Jeffrey Sachs, director of the Earth Institute at Columbia University, writes in a Washington Post opinion piece.

Read more Medical News

› Verified 6 days ago

Entity NameMidstate Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154425288
PECOS PAC ID: 7416840699
Enrollment ID: O20040203000244

News Archive

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.

Fetal exposure to crude oil chemical may increase risk of heart disease

While it may be years before the health effects of the 2010 oil spill in the Gulf of Mexico are known, a new study shows that fetal exposure to a chemical found in crude oil is associated with an increased risk of congenital heart disease.

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

Novel immunotherapeutic shows promise against chronic hepatitis B

A novel immunotherapeutic in early development for chronic hepatitis B (CHB), TG1050, has been shown to reach the clinical goals that are considered to be the hallmarks of a cure for CHB, according to results revealed today at The International Liver Congress 2015.

Sachs says he is 'eager for challenge' of World Bank presidency

The new president of the World Bank "should come to office understanding the realities of flooded villages, drought-ridden farms, desperate mothers hovering over comatose, malaria-infected children, and teenage girls unable to pay high school tuition. More than knowing these realities, and caring to end them, the bank president should understand their causes and interconnected solutions," Jeffrey Sachs, director of the Earth Institute at Columbia University, writes in a Washington Post opinion piece.

Read more Medical News

› Verified 6 days ago

Entity NameThe William W Backus Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467517235
PECOS PAC ID: 0749170645
Enrollment ID: O20040316000739

News Archive

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.

Fetal exposure to crude oil chemical may increase risk of heart disease

While it may be years before the health effects of the 2010 oil spill in the Gulf of Mexico are known, a new study shows that fetal exposure to a chemical found in crude oil is associated with an increased risk of congenital heart disease.

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

Novel immunotherapeutic shows promise against chronic hepatitis B

A novel immunotherapeutic in early development for chronic hepatitis B (CHB), TG1050, has been shown to reach the clinical goals that are considered to be the hallmarks of a cure for CHB, according to results revealed today at The International Liver Congress 2015.

Sachs says he is 'eager for challenge' of World Bank presidency

The new president of the World Bank "should come to office understanding the realities of flooded villages, drought-ridden farms, desperate mothers hovering over comatose, malaria-infected children, and teenage girls unable to pay high school tuition. More than knowing these realities, and caring to end them, the bank president should understand their causes and interconnected solutions," Jeffrey Sachs, director of the Earth Institute at Columbia University, writes in a Washington Post opinion piece.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sheila Santhappa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sheila Santhappa, MD
1290 Silas Deane Highway, Hartford Healthcare Cvo Provider Enrollment,
Wethersfield, CT 06109-4337

Ph: (860) 972-9047
Sheila Santhappa, MD
100 Grand St,
New Britain, CT 06052-2016

Ph: (608) 224-5305

News Archive

Adding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.

Fetal exposure to crude oil chemical may increase risk of heart disease

While it may be years before the health effects of the 2010 oil spill in the Gulf of Mexico are known, a new study shows that fetal exposure to a chemical found in crude oil is associated with an increased risk of congenital heart disease.

CPEX Pharmaceuticals files definitive proxy materials with SEC, mails open letter to shareholders

CPEX Pharmaceuticals, Inc. today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting.

Novel immunotherapeutic shows promise against chronic hepatitis B

A novel immunotherapeutic in early development for chronic hepatitis B (CHB), TG1050, has been shown to reach the clinical goals that are considered to be the hallmarks of a cure for CHB, according to results revealed today at The International Liver Congress 2015.

Sachs says he is 'eager for challenge' of World Bank presidency

The new president of the World Bank "should come to office understanding the realities of flooded villages, drought-ridden farms, desperate mothers hovering over comatose, malaria-infected children, and teenage girls unable to pay high school tuition. More than knowing these realities, and caring to end them, the bank president should understand their causes and interconnected solutions," Jeffrey Sachs, director of the Earth Institute at Columbia University, writes in a Washington Post opinion piece.

Read more News

› Verified 6 days ago


Psychiatry & Neurology Doctors in New Britain, CT

Dr. Michael Balkunas, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 100 Grand St, Ondrea Chasse, Medical Staff Office, New Britain, CT 06052
Phone: 860-224-5305    
Kevin J Felice, D.O.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2150 Corbin Ave, New Britain, CT 06053
Phone: 860-827-4924    
Dr. Marc Kawalick, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 35 Pearl St, New Britain, CT 06051
Phone: 860-223-3810    
Dr. Barry Spass, M.D.
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 35 Pearl St, New Britain, CT 06051
Phone: 860-223-3810    
Dr. Todd Pinter, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 233 Main St, New Britain, CT 06051
Phone: 860-826-1358    Fax: 860-229-8886
Dr. Patricia Aguayo, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2150 Corbin Ave, New Britain, CT 06053
Phone: 860-612-6386    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.